Abstract
Sleep disturbance is one of the most common and troubling symptoms that harm the quality of life throughout all phases of treatment and stages of the illness among patients with cancer. The aim of this meta-analysis is to examine the present status of sleep disturbance prevalence in patients with cancer. The following databases were searched: PubMed, CINAHL, MEDLINE, EMBASE, PsycINFO, from inception to April 2021. Prevalence rates were pooled with meta-analysis using a random-effects model. A total of 160 studies (N = 46,279) published between 1998 and 2021 met the inclusion criteria. The overall prevalence of sleep disturbance was 60.7% (26,448/46,279 participants, 95% CI 58.1–63.3%) with significant heterogeneity between studies (p <.000, τ 2 =.0000, I 2 = 96.4%). This meta-analysis highlights the importance of developing optimal monitoring strategies to reduce sleep disturbance and improve the quality of life of cancer patients.
| Original language | English |
|---|---|
| Pages (from-to) | 1107-1123 |
| Number of pages | 17 |
| Journal | Clinical Nursing Research |
| Volume | 31 |
| Issue number | 6 |
| Early online date | 28 Apr 2022 |
| DOIs | |
| Publication status | Published - 1 Jul 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cancer
- insomnia
- meta-analysis
- prevalence
- sleep disturbance
Fingerprint
Dive into the research topics of 'Prevalence of Sleep Disturbance in Patients with Cancer: A Systematic Review and Meta-Analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver